Reverse transcriptase

A reverse transcriptase (RT) is an enzyme that uses an RNA molecule as a template to synthesize a complementary DNA molecule, through a process termed reverse transcription.

Uses your system voice; voice and rate in settings.

≈ 6 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

A reverse transcriptase (RT) is an enzyme that uses an RNA molecule as a template to synthesize a complementary DNA molecule, through a process termed reverse transcription. Reverse transcriptases are used by viruses such as HIV and hepatitis B to replicate their genomes, by retrotransposon mobile genetic elements to proliferate within the host genome, and by eukaryotic cells to extend the telomeres at the ends of their linear chromosomes.

The process does not violate the flows of genetic information as described by the classical central dogma, but rather expands it to include transfers of information from RNA to DNA. Retroviral RT has three sequential biochemical activities: RNA-dependent DNA polymerase activity, ribonuclease H (RNase H), and DNA-dependent DNA polymerase activity.

Collectively, these activities enable the enzyme to convert single-stranded RNA into double-stranded cDNA. In retroviruses and retrotransposons, this cDNA can then be endogenized into the host genome, from which new RNA copies can be made via host-cell transcription.

The same sequence of reactions is widely used in the laboratory to convert RNA to DNA for use in molecular cloning, RNA sequencing, polymerase chain reaction (PCR), or genome analysis.

Process of reverse transcription or retrotranscription

Reverse transcriptase creates double-stranded DNA from an RNA template. In virus species with reverse transcriptase lacking DNA-dependent DNA polymerase activity, creation of double-stranded DNA can possibly be done by host-encoded DNA polymerase δ, mistaking the viral DNA-RNA for a primer and synthesizing a double-stranded DNA by a similar mechanism as in primer removal, where the newly synthesized DNA displaces the original RNA template.

The process of reverse transcription, also called retrotranscription, is extremely error-prone, and it is during this step that mutations may occur. Such mutations may cause drug resistance. Lysyl tRNA acts as a primer and hybridizes to a complementary part of the virus RNA genome called the primer binding site or PBS.

Reverse transcriptase then adds DNA nucleotides onto the 3′ end of the primer, synthesizing DNA complementary to the U5 (non-coding region) and R region (a direct repeat found at both ends of the RNA molecule) of the viral RNA. A domain on the reverse transcriptase enzyme called RNAse H degrades the U5 and R regions on the 5′ end of the RNA.

The tRNA primer then "jumps" to the 3′ end of the viral genome, and the newly synthesized DNA strands hybridizes to the complementary R region on the RNA. The complementary DNA (cDNA) synthesized in (1) is further extended. The majority of viral RNA is degraded by RNAse H, leaving only the PP sequence.

Synthesis of the second DNA strand begins, using the remaining PP fragment of viral RNA as a primer. The tRNA primer leaves and a "jump" happens. The PBS from the second strand hybridizes with the complementary PBS on the first strand.

Both strands are extended to form a complete double-stranded DNA copy of the original viral RNA genome, which can then be incorporated into the host's genome by the enzyme integrase. Creation of double-stranded DNA also involves strand transfer, in which there is a translocation of short DNA product from initial RNA-dependent DNA synthesis to acceptor template regions at the other end of the genome, which are later reached and processed by the reverse transcriptase for its DNA-dependent DNA activity.

Retroviral RNA is arranged in 5′ terminus to 3′ terminus. The site where the primer is annealed to viral RNA is called the primer-binding site (PBS). The RNA 5′end to the PBS site is called U5, and the RNA 3′ end to the PBS is called the leader.

The tRNA primer is unwound between 14 and 22 nucleotides and forms a base-paired duplex with the viral RNA at PBS. The fact that the PBS is located near the 5′ terminus of viral RNA is unusual because reverse transcriptase synthesize DNA from 3′ end of the primer in the 5′ to 3′ direction (with respect to the newly synthesized DNA strand).

Therefore, the primer and reverse transcriptase must be relocated to 3′ end of viral RNA. In order to accomplish this reposition, multiple steps and various enzymes including DNA polymerase, ribonuclease H (RNase H) and polynucleotide unwinding are needed.

The HIV reverse transcriptase also has ribonuclease activity that degrades the viral RNA during the synthesis of cDNA, as well as DNA-dependent DNA polymerase activity that copies the sense cDNA strand into an antisense DNA to form a double-stranded viral DNA intermediate (vDNA). The HIV viral RNA structural elements regulate the progression of reverse transcription.

Template switching

Two RNA genomes are packaged into each retrovirus particle, but, after an infection, each virus generates only one provirus. After infection, reverse transcription is accompanied by template switching between the two genome copies (copy choice recombination). There are two models that suggest why RNA transcriptase switches templates.

The first, the forced copy-choice model, proposes that reverse transcriptase changes the RNA template when it encounters a nick, implying that recombination is obligatory to maintaining virus genome integrity. The second, the dynamic choice model, suggests that reverse transcriptase changes templates when the RNAse function and the polymerase function are not in sync rate-wise, implying that recombination occurs at random and is not in response to genomic damage.

A study by Rawson et al. supported both models of recombination. From 5 to 14 recombination events per genome occur at each replication cycle. Template switching (recombination) appears to be necessary for maintaining genome integrity and as a repair mechanism for salvaging damaged genomes.

Applications

(AZT), a drug used to inhibit reverse transcriptase animation of reverse transcriptase action and three reverse transcriptase inhibitors Molecule of the month (September 2002) at the RCSB PDB HIV Replication 3D Medical Animation. (Nov 2008). Video by Boehringer Ingelheim.

TWiV 904: 50 years of reverse transcriptase Vincent Racaniello travels to Cold Spring Harbor Laboratory to speak with David Baltimore, John Coffin (scientist), and Harold Varmus about the discovery in 1970 of retroviral reverse transcriptase and its impact on life sciences research.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1362809964 under CC BY-SA 4.0; modifications have been made.

Words in each sectionProcess of reverse tran…Process of reverse transcription or retrotranscriptionProcess of reverse transcription or retrotranscription: 558 words558Template switchingTemplate switchingTemplate switching: 159 words159ApplicationsApplicationsApplications: 102 words102
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot enwiki-001362809964 · captured 2026-07-06 · ledger · version history

Cite this page as: encyclopegia.org, “Reverse transcriptase”, snapshot enwiki-001362809964. https://encyclopegia.org/a/reverse-transcriptase

Sources cited in this revision

12 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.